A Cedars-Sinai Heart Institute cardiologist has been awarded a three-year, nearly $1 million grant from the Muscular Dystrophy Association (MDA) to study whether drugs used to treat erectile dysfunction could also be used to improve muscle blood flow and reduce fatigue in muscular dystrophy patients. The study, led by Ronald G. Victor, M.D…

Read The Full [...] Read more »

A Cedars-Sinai Heart Institute cardiologist has been awarded a three-year, nearly $1 million grant from the Muscular Dystrophy Association (MDA) to study whether drugs used to treat erectile dysfunction could also be used to improve muscle blood flow and reduce fatigue in muscular dystrophy patients. The study, led by Ronald G. Victor, M.D…

Read The [...] Read more »

UroToday.com – Erectile dysfunction is one of the most relevant functional complications following radical prostatectomy. No study had analyzed the predictors of potency recovery in a series of patients undergoing robot-assisted laparoscopic radical prostatectomy (RALP). Moreover, Briganti et al…

Read The Full Article…Preoperative Criteria To Select Patients For Bilateral Nerve Sparing Robotic-Assisted Radical Prostatectomy [...] Read more »

UroToday.com – Erectile dysfunction is one of the most relevant functional complications following radical prostatectomy. No study had analyzed the predictors of potency recovery in a series of patients undergoing robot-assisted laparoscopic radical prostatectomy (RALP). Moreover, Briganti et al…

Read The Full Article…Preoperative Criteria To Select Patients For Bilateral Nerve Sparing Robotic-Assisted Radical Prostatectomy [...] Read more »

A study led by German researchers found that erectile dysfunction was a strong predictor of death from all causes as well as death from heart attack, stroke and heart failure in men with cardiovascular disease. You can read about the findings in a paper published online before print on 15 March in the Circulation, [...] Read more »

Erectile dysfunction (ED) is a strong predictor of death from all causes and of heart attack, stroke and heart failure in men with cardiovascular disease (CVD), German researchers reported in Circulation: Journal of the American Heart Association…

Read The Full Article…Erectile Dysfunction Strong Predictor Of Death, Cardiovascular Outcomes Read more »

Janssen-Cilag announced that PRILIGY® (dapoxetine) is now approved and available for use in New Zealand for the treatment of premature ejaculation (PE) in men 18-64 years of age. PE is a common men’s medical condition, but it is rarely talked about. However, it is widespread and could affect the quality of life of an [...] Read more »

Rexahn Pharmaceuticals, Inc. (NYSE Amex: RNN), a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, announced that it has submitted a Phase IIb protocol to the FDA for ZoraxelTM for the treatment of erectile dysfunction (ED). “The progression of Zoraxel’s clinical program is very encouraging,” said Rexahn Chief [...] Read more »

News reports coming out of the UK and Australia show evidence of prescription ingredients in many “natural” herb remedies sold on the Internet to treat erectile dysfunction (ED). These popular online supplements, which claim to consist only of homeopathic ingredients, are often improperly labeled and may actually contain dangerous ingredients. Dr. J…

Read The Full Article…Urologist [...] Read more »

Global Health Ventures Inc. (OTCBB:GHLV), or the “Company”, is pleased to announce that it has engaged Clinical Investigations Ltd. of United Kingdom to design and carry out the human clinical trials for X-Excite in Europe under the European Regulatory Guidelines (EMEA)…

Read The Full Article…Global Health Ventures To Initiate Human Clinical Trials In Europe For X-Excite, [...] Read more »